- Home
- DCTH vs TALK Comparison
DCTH vs TALK Comparison
Compare DCTH & TALK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- TALK
- Stock Information
- Founded
- DCTH 1988
- TALK 2012
- Country
- DCTH United States
- TALK United States
- Employees
- DCTH N/A
- TALK N/A
- Industry
- DCTH Medical/Dental Instruments
- TALK Medical/Nursing Services
- Sector
- DCTH Health Care
- TALK Health Care
- Exchange
- DCTH Nasdaq
- TALK Nasdaq
- Market Cap
- DCTH 388.3M
- TALK 437.1M
- IPO Year
- DCTH N/A
- TALK N/A
- Fundamental
- Price
- DCTH $11.75
- TALK $2.65
- Analyst Decision
- DCTH Strong Buy
- TALK Buy
- Analyst Count
- DCTH 4
- TALK 6
- Target Price
- DCTH $24.50
- TALK $4.50
- AVG Volume (30 Days)
- DCTH 497.8K
- TALK 1.0M
- Earning Date
- DCTH 11-07-2025
- TALK 10-28-2025
- Dividend Yield
- DCTH N/A
- TALK N/A
- EPS Growth
- DCTH N/A
- TALK N/A
- EPS
- DCTH 0.06
- TALK 0.02
- Revenue
- DCTH $70,240,000.00
- TALK $202,611,000.00
- Revenue This Year
- DCTH $159.22
- TALK $22.35
- Revenue Next Year
- DCTH $42.78
- TALK $21.66
- P/E Ratio
- DCTH $211.26
- TALK $153.76
- Revenue Growth
- DCTH 491.35
- TALK 17.43
- 52 Week Low
- DCTH $8.08
- TALK $1.88
- 52 Week High
- DCTH $18.23
- TALK $4.36
- Technical
- Relative Strength Index (RSI)
- DCTH 59.13
- TALK 54.16
- Support Level
- DCTH $10.61
- TALK $2.49
- Resistance Level
- DCTH $11.38
- TALK $2.64
- Average True Range (ATR)
- DCTH 0.49
- TALK 0.09
- MACD
- DCTH 0.06
- TALK -0.01
- Stochastic Oscillator
- DCTH 79.61
- TALK 71.11
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
About TALK Talkspace Inc.
Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.